Nutanix price target lowered to $82 from $90 at Morgan Stanley

Morgan Stanley analyst Meta Marshall lowered the firm’s price target on Nutanix (NTNX) to $82 from $90 and keeps an Overweight rating on the shares. A Q1 revenue miss and lowered FY26 top-line outlook are “messy,” but largely reflect revenue recognition timing, the analyst tells investors. With NNARR growth accelerating, the firm’s thesis remains intact, but the firm lowers its price target on lower revenue visibility, the analyst added.